Follow
Ehab Moussa
Ehab Moussa
Verified email at abbvie.com
Title
Cited by
Cited by
Year
Immunogenicity of therapeutic protein aggregates
EM Moussa, JP Panchal, BS Moorthy, JS Blum, MK Joubert, LO Narhi, ...
Journal of pharmaceutical sciences 105 (2), 417-430, 2016
5582016
The evolutionary dynamics of variant antigen genes in Babesia reveal a history of genomic innovation underlying host–parasite interaction
AP Jackson, TD Otto, A Darby, A Ramaprasad, D Xia, IE Echaide, ...
Nucleic acids research 42 (11), 7113-7131, 2014
1132014
Predictive models of lyophilization process for development, scale-up/tech transfer and manufacturing
T Zhu, EM Moussa, M Witting, D Zhou, K Sinha, M Hirth, M Gastens, ...
European Journal of Pharmaceutics and Biopharmaceutics 128, 363-378, 2018
552018
Foslevodopa/foscarbidopa: a new subcutaneous treatment for Parkinson's disease
M Rosebraugh, EA Voight, EM Moussa, F Jameel, X Lou, GGZ Zhang, ...
Annals of neurology 90 (1), 52-61, 2021
542021
Comprehensive Evaluation of Toxoplasma gondii VEG and Neospora caninum LIV Genomes with Tachyzoite Stage Transcriptome and Proteome Defines Novel …
A Ramaprasad, T Mourier, R Naeem, TB Malas, E Moussa, A Panigrahi, ...
Plos one 10 (4), e0124473, 2015
382015
Effects of drying process on an IgG1 monoclonal antibody using solid-state hydrogen deuterium exchange with mass spectrometric analysis (ssHDX-MS)
EM Moussa, NE Wilson, QT Zhou, SK Singh, S Nema, EM Topp
Pharmaceutical research 35, 1-12, 2018
362018
Interleukin-10 Regulates Hepcidin in Plasmodium falciparum Malaria
H Huang, AA Lamikanra, MS Alkaitis, ML Thézénas, A Ramaprasad, ...
PloS one 9 (2), e88408, 2014
342014
Physical Characterization and Innate Immunogenicity of Aggregated Intravenous Immunoglobulin (IGIV) in an In Vitro Cell-Based Model
EM Moussa, J Kotarek, JS Blum, E Marszal, EM Topp
Pharmaceutical Research 33, 1736-1751, 2016
292016
Recommended best practices for lyophilization validation—2021 part I: process design and modeling
F Jameel, A Alexeenko, A Bhambhani, G Sacha, T Zhu, S Tchessalov, ...
AAPS PharmSciTech 22 (7), 221, 2021
222021
Proteomic profiling of the plasma of Gambian children with cerebral malaria
EM Moussa, H Huang, ML Thézénas, R Fischer, A Ramaprasad, ...
Malaria Journal 17, 1-8, 2018
212018
Probing the conformation of an IgG1 monoclonal antibody in lyophilized solids using solid-state hydrogen–deuterium exchange with mass spectrometric analysis (ssHDX-MS)
EM Moussa, SK Singh, M Kimmel, S Nema, EM Topp
Molecular Pharmaceutics 15 (2), 356-368, 2018
192018
Recommended best practices for lyophilization validation 2021 part II: process qualification and continued process verification
F Jameel, A Alexeenko, A Bhambhani, G Sacha, T Zhu, S Tchessalov, ...
AAPS PharmSciTech 22, 1-25, 2021
162021
Structure of monoclonal antibodies
BS Moorthy, B Xie, EM Moussa, LK Iyer, S Chandrasekhar, JP Panchal, ...
Biobetters: Protein Engineering to Approach the Curative, 81-89, 2015
142015
End-to-end approach to surfactant selection, risk mitigation, and control strategies for protein-based therapeutics
AM Morales, A Sreedhara, J Buecheler, S Brosig, D Chou, T Christian, ...
The AAPS journal 25 (1), 6, 2022
102022
Accelerated storage for shelf-life prediction of lyophiles: temperature dependence of degradation of amorphous small molecular weight drugs and proteins
E Shalaev, S Ohtake, EM Moussa, J Searles, S Nail, CJ Roberts
Journal of Pharmaceutical Sciences 112 (6), 1509-1522, 2023
92023
Chapter 1: monoclonal antibodies: structure, physicochemical stability, and protein engineering
BJ Mills, EM Moussa, F Jameel
Development of Biopharmaceutical Drug-Device Products, 3-26, 2020
82020
Proteomic profiling of the brain of mice with experimental cerebral malaria
E Moussa, H Huang, M Ahras, A Lall, ML Thezenas, R Fischer, ...
Journal of proteomics 180, 61-69, 2018
62018
Chapter 21: Rational Design of a Freeze-Drying Process for Protein Products
F Jameel, T Zhu, EM Moussa, BJ Mills
Development of Biopharmaceutical Drug-Device Products, 499-537, 2020
52020
In-situ molecular vapor composition measurements during Lyophilization
ET Liechty, AD Strongrich, EM Moussa, E Topp, AA Alexeenko
Pharmaceutical Research 35, 1-10, 2018
42018
Chapter 16: Development of robust lyophilization process for therapeutic proteins: a case study
EM Moussa, T Zhu, F Jameel
Development of biopharmaceutical drug-device products, 391-403, 2020
32020
The system can't perform the operation now. Try again later.
Articles 1–20